Clinical research regulation: challenges to the institutional review board system

References 

1. Halwani TM, Takrouri M. Medical laws and ethics of Babylon as read in Hammurabi's code (history). Internet J Law Healthc Ethics. 2007;Available at: http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijlhe/vol4n2/babylon.xmlAccessed January 24, 2009
2. Whitney SN, Alcser K, Schneider CE, McCullough LB, McGuire AL, Volk RJ. Principal investigator views of the IRB system. Int J Med Sci. 2008;5:68–72
3. Larson E, Zwanziger J, Stone P. A survey of IRB process in 68 U.S. hospitals. J Nurs Scholarsh. 2004;36:260–264
   • MEDLINE
   • CrossRef
4. Fost N, Levine RJ. The dysregulation of human subjects research. JAMA. 2007;298:2196–2198
   • CrossRef
5. Ness RB. Influence of the HIPAA privacy rule on health research. JAMA. 2007;298:2164–2170
   • CrossRef
6. Gelsinger P, Shamoo SA. Eight years after Jesse's death, are human research subjects any safer?. Hastings Cent Rep. 2008;38:25
7. Office of the Inspector General . United States Department of Health & Human Services. In: The Food and Drug Administration's oversight of clinical trials, in services. 34:2007;OEI-01-06-00160. Available at: http://www.oig.hhs.gov/oei/reports/oei-01-06-00160.pdfAccessed January 25, 2009
8. Bramstedt KA, Kassimatis K. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration. Clin Invest Med. 2004;27:316–323
   • MEDLINE
9. Getz KA. Prevention of fraud and non-compliance in clinical research. In: Presented at: Drug Information Association Annual Meeting, Washington, DC. 2004;
10. Gunsalus CK, Bruner E, Burbules E, et al. The Illinois white paper–improving the system for protecting human subjects: counteracting IRB mission creep. U Illinois Law & Economics Research Paper No. LE06-016. Social Science Research Network. Available at: http://ssrn.com/abstract=902995Accessed January 25, 2009
11. Center for Information & Study on Clinical Research Participation . CISCRPs facts about clinical research. Facts and figures. Available at: http://www.ciscrp.org/information/facts.aspAccessed January 25, 2009
12. Penslar RL. United States Department of Health & Human Services. Protecting Human research subjects: institutional review board guidebook. Washington, DC: U.S. Department of Health & Human Services; 1993;
13. National Bioethics Advisory Commission . In: Ethical and policy issues in research involving human participants. Bethesda (MD): National Bioethics Advisory Commission; 2001;p. 19
14. Vanderpool H. An ethics primer for institutional review boards. In:  Bankert EA,  Amdur R editor. Institutional review board: management and function. 2nd ed.. Sudbury (MA): Jones and Bartlett Publishers Inc; 2006;p. 3
15. Bankert EA, Amdur R. The institutional review board: definition and federal oversight. In:  Bankert EA,  Amdur R editor. Institutional review board: management and function. 2nd ed.. Sudbury (MA): Jones and Bartlett Publishers Inc; 2006;p. 24–25
16. United States Department of Health & Human Services . OHRP fact sheet. Available at: http://www.hhs.gov/ohrp/about/ohrpfactsheet.htmAccessed December 16, 2008
17. Institute of Medicine . Responsible research–a systems approach to protecting research participants. Washington, DC: National Academies Press; 2003;
18. Gunsalus CK, Bruner EM, Burbules NC, et al. Mission creep in the IRB world. Science. 2006;312:1441
    • CrossRef
19. Kerr S. On the folly of rewarding A while hoping for B. Acad Manage Exec. 1995;9:7–14
20. Emanuel EJ, Wood A, Fleischman A, et al. Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med. 2004;141:282–291
21. Levine RJ. Ethics and regulation of clinical research. 2nd ed.. New Haven (CT): Yale University Press; 1988;
22. Burke GS. Looking into the institutional review board: observations from both sides of the table. J Nutr. 2005;135:921–924
    • MEDLINE
23. Kass NE, Sugarman J, Faden R, Schoch-Spana M. Trust, the fragile foundation of contemporary biomedical research. Hastings Cent Rep. 1996;26:
24. Amdur RJ. The limits of institutional review board authority. In:  Bankert EA,  Amdur R editor. Institutional review board: management and function. 2nd ed.. Sudbury (MA): Jones and Bartlett Publishers Inc; 2006;p. 26–28
25. Resnik DB. Do informed consents really matter?. Contem Clin Trials. 2008;[in press]
26. Speers MA. Testimony to the Committee on Health, Education, Labor, and Pensions. Subcommittee on Public Health. Washington, DC: United States Senate Hearing; 2002;
27. Association for the Accreditation of Human Research Protection Programs . The five domains of standards. Available at: http://www.aahrpp.org/www.aspx?PageID=232009;Accessed January 25, 2009
28. United States Department of Health & Human Services . OHRP quality assurance/quality improvement: A guided self-assessment for human research protection programs. Available at: http://www.hhs.gov/ohrp/qi/2008;Accessed January 25, 2009
29. Public Responsibility in Medicine and Research PRIM&R . Certification. Available at: http://www.primr.org/Certification.aspx?id=74Accessed January 25, 2009
30. Program DON HRPP: human research certification - is it for you?. Res Prot Update. 2007;2:1–2Available at: http://www.onr.navy.mil/sci_tech/34/docs/hrp_newsleter_0706.pdfAccessed January 25, 2009
31. Dyrbye LN, Thomas MR, Papp KK, Durning SJ. Clinical educators' experiences with institutional review boards: results of a national survey. Acad Med. 2008;83:590–595
    • CrossRef
32. Forster D. Independent institutional review boards. Seton Hall Law Rev. 2003;32:513–523
    • MEDLINE
33. Macklin R. How independent are IRBs?. IRB. 2008;30:15–19
34. Peckman S. A Shared responsibility for protecting human subjects. In:  Bankert EA,  Amdur R editor. Institutional review board: management and function. 2nd ed.. Sudbury (MA): Jones and Bartlett Publishers Inc; 2006;p. 16–20